Viewing nowCombinationNekpo Tablet 5/80 mg
Valsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Youngil Pharmaceutical Co., Ltd.

MFDS item code 201400162 · Approved 2014.01.15 · Insurance code 649404610
Treatment of essential hypertension not controlled with monotherapy
This medication can effectively lower blood pressure in patients with essential hypertension who have difficulty controlling their blood pressure with monotherapy using amlodipine or valsartan. It helps reduce the risk of cardiovascular-related complications and improves health.
The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended to take it at the same time each day (e.g., in the morning). Before treatment with this drug, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, direct conversion to this drug may be considered if blood pressure is not adequately controlled with monotherapy using the individual components, as follows. ㆍ 5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ 5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ 10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this drug should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80 mg. Do not administer this drug to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction/cholestasis. Patients aged 65 years or older: Use caution when increasing the dose.
Pediatric patients under 18 years of age: Use of this drug is not recommended because its safety and efficacy have not been established.
This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be stopped immediately if pregnancy is confirmed. Patients with allergies to any ingredient in this medication, pregnant or breastfeeding women, and patients with severe kidney or liver impairment should not take this medication. Patients who are sodium or fluid depleted may experience hypotension, so their condition should be carefully monitored before and during treatment. Blood pressure and condition should be closely observed. Patients with high potassium levels or those taking medications that increase potassium should have their potassium levels monitored frequently. Patients with kidney problems, kidney transplant recipients, those with a history of angioedema, and patients after heart failure or myocardial infarction should use this medication with caution and consult a specialist if necessary. During the use of this medication, side effects such as dizziness, headache, edema, cough, and gastrointestinal disturbances may occur, so any unusual symptoms should be reported to healthcare personnel promptly. Caution is needed when driving or operating machinery, as dizziness or fatigue may occur. Drug interactions may occur when taken with other medications, so patients should inform their healthcare provider of any other medications they are taking. It is advisable for pregnant or breastfeeding women to avoid taking this medication, and it is not recommended for children due to insufficient evidence of safety and efficacy. Overdosage may lead to severe hypotension or heart problems; therefore, the dosage must be strictly adhered to, and patients should go to the hospital immediately in case of an overdose. Periodic blood pressure and kidney function tests may be required during the medication period, so patients should follow their healthcare provider's instructions regarding testing.
nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, position-related dizziness, paresthesia, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, hyperhidrosis, pruritus, joint swelling, low back pain, arthritis, muscle spasms, lethargy, polyuria, nocturia, erectile dysfunction, edema, peripheral edema, facial edema, generalized edema, fatigue, flushing, weakness, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, including serum sickness hypersensitivity, increased serum potassium, vasculitis, elevated liver function tests, vascular edema, myalgia, renal failure, kidney damage, increased serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory tract infection, viral infection, diplopia, thrombocytopenic purpura, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremors, sensory impairment, taste distortion, peripheral neuropathy, hypermuscle tonicity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, vascular edema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urination disorders, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, elevated liver enzymes, breast discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, nervousness, Stevens-Johnson syndrome, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid contact with air or moisture and is best kept at room temperature between 1 and 30 degrees Celsius. Following the appropriate temperature and storage methods will help maintain the medication's effectiveness and safety.
Yellow round film-coated tablets
Bottle packaging - 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Youngil Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.